About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
L
Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving Efficacy in Recovery? What Are the Current ACR Recommendations for COVID-19 Positive and Negative Patients?
By
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
FEATURING
Leanna Wise
By
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
FEATURING
Leanna Wise
372 views
November 24, 2020
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
15:26
Cleveland Clinic Rheumatology and Immunology Series
The Facts About COVID-19 Delta Breakthrough Infection and Vaccine Bo…
Feat.
L. Calabrese
01:58
Covid-19 Global Rheumatology Alliance
The COVID-19 Global Rheumatology Alliance: Collecting Evidence-Based…
Feat.
P. Robinson,
J. Yazdany
29:14
Cleveland Clinic Rheumatology
Cytokine Storm: Where Rheumatologists, Oncologists, and ID Meet
Feat.
D. Fajgenbaum
14:51
ACR Convergence 2021 Coverage
Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…
Feat.
S. Sattui Cortes
08:33
The Journal of Rheumatology
HCQ in Patients With Rheumatic Disease Complicated by COVID-19: Clar…
Feat.
S. J. Balevic
07:43
Cleveland Clinic Rheumatology and Immunology Series
Cleveland Clinic ACR 2020 Updates on COVID-19: Has Tocilizumab Prove…
Feat.
L. Calabrese
18:35
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID…
Feat.
L. Wise
29:06
Cleveland Clinic Rheumatology
Vaccines for IMIDS: State of the Art
Feat.
C. Calabrese
51:16
Yale School of Medicine
COVID-19 and Rheumatic Diseases
Feat.
V. Chowdhary
24:32
RheumNow
Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of …
Feat.
J. Cush,
R. Tate,
Y. Yusof,
B. Mehta,
O. Petryna
19:39
Cleveland Clinic Rheumatology
Principles of Managing COVID-19 in High Risk Outpatients
Feat.
C. Calabrese
22:24
Cleveland Clinic Rheumatology
JAK Inhibitors in the COVID-19 Era: Assessing the Risks and Benefit
Feat.
K. Winthrop
05:35
The Journal of Rheumatology
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection…
Feat.
J. Curtis
22:39
The Journal of Rheumatology
The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment
Feat.
E. Silverman,
J. Rosenbaum,
J. Reveille,
K. Winthrop
20:38
Cleveland Clinic Rheumatology
COVID-19 and the Risks From Immunomodulatory Therapies
Feat.
Z. Wallace
10:00
RheumNow
RheumNow Updates on Pemphigus Vulgaris, the Efficacy of JAK Inhibito…
Feat.
J. Cush
05:29
RheumNow
Rheumatic Disease Patients with COVID-19: Is Timing Important for Bi…
Feat.
J. Cush
26:25
Cleveland Clinic Rheumatology
Hyperinflammation and Immunomodulatory Drugs Trials in COVID-19
Feat.
P. Mehta
14:08
Cleveland Clinic Rheumatology
Managing COVID-19 in Immune-Mediated Inflammatory Disease Patients: …
Feat.
C. Calabrese,
L. Calabrese,
P. Mehta
26:24
Hospital for Special Surgery
COVID-19 in Rheumatology Patients: What Are the Risks and Side Effec…
Feat.
S. Sattui Cortes,
R. Mackenzie
